tirzepatide cortisol study versus Semaglutide for Obesity Management: What the SURMOUNT-5 Trial Tells Us Brain activity associated with breakthrough

FDA, ,

GoodRx (weight loss comparisons, availability)

Whilst no clinically significant interaction is listed in UK product information, overlapping side effectsparticularly nausea, vomiting, and constipationmay increase when these medicines are combined

Fat cells produce estrogen through aromatization of androgens, and excessive body fat can lead to elevated estrogen levels and disrupted menstrual cycles

Etheresia Pretorius, orcid.org/0000-0002-9108-2384 Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

Nausea and digestive discomfort are the most common side effects and are usually most noticeable during the first few weeks or after a dose increase